Current Liabilities Cambio Fecha
Abbott USD 14.35B 180M 2023-06
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
Aurora Cannabis CAD 242.3M 109.24M 2023-03
Bristol-Myers Squibb USD 23.46B 3.31B 2023-09
Canopy Growth CAD 196.25M 254.9M 2023-09
Cara Therapeutics USD 22.88M 2.58M 2023-09
Corcept Therapeutics USD 104.5M 17.37M 2023-12
Eisai JPY 307.31B 11.44B 2023-09
Eli Lilly USD 22B 3.08B 2023-09
Marinus Pharmaceuticals USD 30.56M 4.95M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Perrigo USD 1.01B 48.5M 2023-09
Pfizer USD 31.14B 3.51B 2023-09
Revance Therapeutics USD 82.16M 8.08M 2023-09
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12
United Therapeutics USD 804.4M 60.3M 2023-12
Xeris Pharmaceuticals USD 87.04M 7.36M 2023-09



Supernus Pharmaceuticals Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.